By Feng Qirong

On 27th July, good news came from Macau: Nantong intangible cultural heritage medicine ‘Wangshi Baochi Pill’ completed the registration and settlement of traditional Chinese patent medicine in Macau, and became the first Chinese intangible cultural heritage product and confidential formula variety launched in Macau.

It not only marks that Wangshi Baochi Pill has obtained the qualification to enter the Macau market, but also paves the way for radiating Portuguese-speaking countries with Macau as a ‘bridgehead’.

Wangshi Baochi Pill, which is known as the ‘No.1 pill in China’, has significant therapeutic effects on digestive system and respiratory system diseases, covering the entire life cycle. In the past more than ten years, Jinghua Pharmaceutical has continued to deepen pharmacological research, worked together with Harvard Medical School, Peking University, etc., revealed the pharmacological mechanism of Wangshi Baochi Pill in gastrointestinal dynamics and intestinal flora.